Las Vegas Sun

Beckman Coulter Diagnostics Selects Innovaccer Gravity™ as AI and Data Platform for Clinical Laboratory Operations Modernization

Innovaccer Inc., a leading healthcare AI company, today announced that Beckman Coulter Diagnostics, a global clinical diagnostics leader and a Danaher company, has selected Gravity, Innovaccer’s ...

Danaher’s Beckman Coulter AI Lab Push And What It Means For Investors

Beckman Coulter Diagnostics, part of Danaher, announced a partnership with Innovaccer to modernize clinical laboratory operations using AI and a unified data platform. The collaboration centers on ...

Does Danaher’s (DHR) AI Lab Push and Steady Dividend Reveal Its Next Strategic Focus?

Danaher Corporation recently declared a regular quarterly cash dividend of US$0.40 per share, payable on April 24, 2026 to shareholders of record as of March 27, 2026, while its Beckman Coulter ...
FierceBiotech

Beckman Coulter targets midsized diagnostic labs with automated sample prep hardware launch

The past year has put spotlights on two types of diagnostic systems: those that can run as many tests as possible as fast as possible, and the one-offs that can be performed at a kitchen table. With a ...
Nasdaq

Beckman Coulter, Lenco Diagnostic Laboratories deliver more than 20,000 highly accurate COVID-19 antibody tests each week to New York City; Congressman Max Rose and Brooklyn ...

40,000 of Beckman Coulter's new Access SARS-CoV-2 IgG Antibody tests already received by New York City through Lenco Labs Prior to offering the Beckman Coulter SARS-CoV-2 IgG antibody test to patients ...
Seeking Alpha

Beckman Coulter Diagnostics Launches Industry First Fully Automated, High Throughput BD-Tau Research Use Only Immunoassay Test, Advancing Neurodegenerative Clinical Research

BREA, Calif., Sept. 10, 2025 /PRNewswire/ -- Beckman Coulter Diagnostics, a Danaher company and a leader in global clinical diagnostics innovation, today launched the industry's first fully automated ...
Business Wire

Beckman Coulter and Fujirebio Expand Partnership to Develop Patient-friendly, Blood-based Neurodegenerative Disease Diagnostics

BREA, Calif. & TOKYO--(BUSINESS WIRE)--Beckman Coulter Diagnostics, a clinical diagnostics leader, and Fujirebio, a leader in neurological markers and In Vitro Diagnostic (IVD) manufacturing, today ...
Business Wire

Beckman Coulter and Fujirebio Partner to Bolster Access to Patient-friendly, Blood-based Alzheimer’s Disease Test Therapeutics

BREA, Calif. & TOKYO--(BUSINESS WIRE)--Beckman Coulter Diagnostics, a clinical diagnostics leader, and Fujirebio, a leader in neurological markers and In Vitro Diagnostic (IVD) manufacturing, today ...
KXAN

Beckman Coulter and MeMed to Expand Access to Proven Host Immune Response Diagnostic Able to Distinguish Between Bacterial and Viral Infections

MeMed BV is a diagnostic test developed to address management of patients with acute infection in different clinical settings, including Emergency Departments. The MeMed BV test uses machine learning ...
Orange County Business Journal

Beckman Coulter Parent Bids for J&J Diagnostics

Brea-based diagnostic testing machine and supply maker Beckman Coulter Inc. could get some company within parent Danaher Corp.’s life sciences and diagnostics unit. Johnson & Johnson, the New ...
Nasdaq

Beckman Coulter awarded expanded partnership with BARDA to assess sepsis diagnostic and prediction algorithm with COVID-19 patients

BREA, Calif., May 15, 2020 /PRNewswire/ -- Beckman Coulter today announced it was awarded an expanded partnership with BARDA as part of their rapidly expanding COVID-19 medical countermeasure ...
News Medical

Beckman Coulter introduces new SARS-CoV-2 IgM assay in countries accepting the CE Mark

Beckman Coulter, a clinical diagnostics leader, today announced the launch of its Access SARS-CoV-2 Immunoglobulin M (IgM) assay in countries accepting the CE Mark. The new IgM antibody test ...